211 related articles for article (PubMed ID: 16082337)
21. Islet transplantation in the discordant tilapia-to-mouse model: a novel application of alginate microencapsulation in the study of xenograft rejection.
Dickson BC; Yang H; Savelkoul HF; Rowden G; van Rooijen N; Wright JR
Transplantation; 2003 Mar; 75(5):599-606. PubMed ID: 12640296
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.
Safley SA; Kapp LM; Tucker-Burden C; Hering B; Kapp JA; Weber CJ
Transplantation; 2005 Feb; 79(4):409-18. PubMed ID: 15729166
[TBL] [Abstract][Full Text] [Related]
23. CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells.
Loudovaris T; Mandel TE; Charlton B
Transplantation; 1996 Jun; 61(12):1678-84. PubMed ID: 8685943
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping fish-to-mouse islet xenograft rejection: a time course study.
Wright JR; Kearns H; Yang H; Fraser RB; Colp P; Rowden G
Ann Transplant; 1997; 2(3):12-6. PubMed ID: 9869859
[TBL] [Abstract][Full Text] [Related]
25. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs.
Safley SA; Kapp JA; Weber CJ
Cell Transplant; 2002; 11(7):695-705. PubMed ID: 12518896
[TBL] [Abstract][Full Text] [Related]
26. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
[TBL] [Abstract][Full Text] [Related]
27. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
28. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
29. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
30. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
Koulmanda M; Laufer TM; Auchincloss H; Smith RN
Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
[TBL] [Abstract][Full Text] [Related]
31. Role of CD4+ and CD8+ T cells in the rejection of heart or islet xenografts in recipients with xenotolerance in the innate immune compartment.
Devos T; Yan Y; Segers C; Rutgeerts O; Laureys J; Gysemans C; Mathieu C; Waer M
Transplant Proc; 2005; 37(1):516-7. PubMed ID: 15808695
[TBL] [Abstract][Full Text] [Related]
32. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
33. Microencapsulated dog and rat islet xenografts into streptozotocin-diabetic and NOD mice.
Weber CJ; Zabinsi S; Koschitzky T; Rajotte R; Wicker L; Peterson L; D'Agati V; Reemtsma K
Horm Metab Res Suppl; 1990; 25():219-26. PubMed ID: 2088974
[TBL] [Abstract][Full Text] [Related]
34. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
35. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice.
Mariño E; Walters SN; Villanueva JE; Richards JL; Mackay CR; Grey ST
Eur J Immunol; 2014 Apr; 44(4):983-93. PubMed ID: 24435807
[TBL] [Abstract][Full Text] [Related]
36. Long-term function of fish islet xenografts in mice by alginate encapsulation.
Yang H; O'Hali W; Kearns H; Wright JR
Transplantation; 1997 Jul; 64(1):28-32. PubMed ID: 9233696
[TBL] [Abstract][Full Text] [Related]
37. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
38. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
39. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
40. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
